Medical Developments International MVP.AX · AUD

Its shares trade on ASX under the ticker MVP.AX. It has been listed since 15 December 2003. In the fiscal year to 30 June 2026, it reported revenue of A$42.6m and net income of A$626,000. At that date it held total assets of A$68.6m and shareholders' equity of A$55.8m.

Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The company is headquartered in Melbourne, Victoria. The company went IPO on 2003-12-15. The firm is engaged in the manufacture and distribution of a pharmaceutical drug, and medical and veterinary equipment. The firm operates through three segments: Pharmaceuticals, Medical Devices and Veterinary products. The Pharmaceuticals segment is engaged in the sale of Penthrox primarily within Australia and the United Kingdom, and some sales in New Zealand, Eastern Europe, the Middle East and South America. The Medical Devices segment is engaged in the sale of medical devices, particularly the Space Chamber and Breath-Alert PeakFlow meters, primarily within Australia and New Zealand, and some sales in Asia, Europe, the Middle East and North America. The Veterinary Products segment is engaged in the sale of veterinary products within Australia, Europe and the United States. The firm offers a range of products in the areas of pain management, and asthma and resuscitation.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Gordon NaylorNon-Executive Chairman of the BoardA$95,000
• Mr. Brent MacgregorChief Executive OfficerA$1.9m
• Ms. Anita JamesChief Financial OfficerA$505,609
• Ms. Tara EatonCompany Secretary
• Dr. Russell BasserDirectorA$50,000
• Mr. Richard BettsNon-Executive DirectorA$60,000
• Ms. Christine Emmanuel-DonnellyNon-Executive Independent DirectorA$60,000
• Mr. Leon HoareNon-Executive Independent DirectorA$60,000

Overall

15

Environment

17

Social

11

Governance

17

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.